Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongbin Ji

Showing results (171-180 of 214) with videos related to

Pageof 22
Sort By:
Cell Reports|June 29, 2023
Identification of XAF1 as an endogenous AKT inhibitorMin Chen, Kangjunjie Wang, Ying Han, et al.
The Journal of Experimental Medicine|May 28, 2024
TET2-STAT3-CXCL5 nexus promotes neutrophil lipid transfer to fuel lung adeno-to-squamous transitionYun Xue, Yuting Chen, Sijia Sun, et al.
The Journal of Clinical Investigation|January 29, 2019
Cullin5 deficiency promotes small-cell lung cancer metastasis by stabilizing integrin β1Gaoxiang Zhao, Liyan Gong, Dan Su, et al.
Nature Medicine|January 19, 2010
Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growthA McGarry Houghton, Danuta M Rzymkiewicz, Hongbin Ji, et al.
The Journal of Experimental Medicine|June 7, 2024
Correction: TET2-STAT3-CXCL5 nexus promotes neutrophil lipid transfer to fuel lung adeno-to-squamous transitionYun Xue, Yuting Chen, Sijia Sun, et al.
National Science Review|April 13, 2023
Counteracting lineage-specific transcription factor network finely tunes lung adeno-to-squamous transdifferentiation through remodeling tumor immune microenvironmentShijie Tang, Yun Xue, Zhen Qin, et al.
Signal Transduction and Targeted Therapy|September 11, 2025
Coinhibition of the MEK/RTK pathway has high therapeutic efficacy in KRAS-mutant non-small cell lung cancerJun Lu, Minjuan Hu, Yikai Zhao, et al.
Cancer Research|May 19, 2007
Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse modelsHongbin Ji, Zhenxiong Wang, Samanthi A Perera, et al.
Cancer Cell|May 30, 2006
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapiesHongbin Ji, Danan Li, Liang Chen, et al.
Cell Death and Differentiation|January 8, 2026
KMT2D loss drives adeno-to-squamous transition and sensitizes TKI-resistant lung cancer to AURKA inhibitionNana Chen, Mouxiang Fang, Leqi Zhong, et al.
Pageof 22

Showing results (171-180 of 214) with videos related to

Sort By:
Pageof 22
Cell Reports|June 29, 2023
Identification of XAF1 as an endogenous AKT inhibitorMin Chen, Kangjunjie Wang, Ying Han, et al.
The Journal of Experimental Medicine|May 28, 2024
TET2-STAT3-CXCL5 nexus promotes neutrophil lipid transfer to fuel lung adeno-to-squamous transitionYun Xue, Yuting Chen, Sijia Sun, et al.
The Journal of Clinical Investigation|January 29, 2019
Cullin5 deficiency promotes small-cell lung cancer metastasis by stabilizing integrin β1Gaoxiang Zhao, Liyan Gong, Dan Su, et al.
Nature Medicine|January 19, 2010
Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growthA McGarry Houghton, Danuta M Rzymkiewicz, Hongbin Ji, et al.
The Journal of Experimental Medicine|June 7, 2024
Correction: TET2-STAT3-CXCL5 nexus promotes neutrophil lipid transfer to fuel lung adeno-to-squamous transitionYun Xue, Yuting Chen, Sijia Sun, et al.
National Science Review|April 13, 2023
Counteracting lineage-specific transcription factor network finely tunes lung adeno-to-squamous transdifferentiation through remodeling tumor immune microenvironmentShijie Tang, Yun Xue, Zhen Qin, et al.
Signal Transduction and Targeted Therapy|September 11, 2025
Coinhibition of the MEK/RTK pathway has high therapeutic efficacy in KRAS-mutant non-small cell lung cancerJun Lu, Minjuan Hu, Yikai Zhao, et al.
Cancer Research|May 19, 2007
Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse modelsHongbin Ji, Zhenxiong Wang, Samanthi A Perera, et al.
Cancer Cell|May 30, 2006
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapiesHongbin Ji, Danan Li, Liang Chen, et al.
Cell Death and Differentiation|January 8, 2026
KMT2D loss drives adeno-to-squamous transition and sensitizes TKI-resistant lung cancer to AURKA inhibitionNana Chen, Mouxiang Fang, Leqi Zhong, et al.
Pageof 22